brand logo

Am Fam Physician. 2024;110(4):437-439

This clinical content conforms to AAFP criteria for CME.

Author disclosure: No relevant financial relationships.

• Treatment of atopic dermatitis with a midpotency topical corticosteroid once daily or a topical calcineurin inhibitor two to three times per week is safer and more effective for maintenance of remission than episodic treatment of flare-ups.
• Dilute bleach baths are beneficial for moderate to severe cases of atopic dermatitis.
• Systemic corticosteroids, elimination diets, and topical antimicrobial agents should be avoided in patients with atopic dermatitis.
From the AFP Editors

KEY POINTS FOR PRACTICE

• Treatment of atopic dermatitis with a midpotency topical corticosteroid once daily or a topical calcineurin inhibitor two to three times per week is safer and more effective for maintenance of remission than episodic treatment of flare-ups.

• Dilute bleach baths are beneficial for moderate to severe cases of atopic dermatitis.

• Systemic corticosteroids, elimination diets, and topical antimicrobial agents should be avoided in patients with atopic dermatitis .

From the AFP Editors

Already a member/subscriber?  Log In

Subscribe

From $165
  • Immediate, unlimited access to all AFP content
  • More than 130 CME credits/year
  • AAFP app access
  • Print delivery available
Subscribe

Issue Access

$59.95
  • Immediate, unlimited access to this issue's content
  • CME credits
  • AAFP app access
  • Print delivery available
Purchase Access:  Learn More

Coverage of guidelines from other organizations does not imply endorsement by AFP or the AAFP.

This series is coordinated by Michael J. Arnold, MD, Assistant Medical Editor.

A collection of Practice Guidelines published in AFP is available at https://www.aafp.org/afp/practguide.

Continue Reading

More in AFP

Copyright © 2024 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.